Women’s Health: Organon has a portfolio of contraceptive and fertility brands anchored by market exclusivity for ImplanonNxt (etonogestrel implant) that has long-term growth potential. In India Organon is having 16% market share in the contraception and fertility market. Mumbai, India, June 3 – Organon , today celebrates its launch as the only global company of its size focused on women’s health. In India, Organon will be operating in women’s healthcare fertility , dermatology, respiratory and bone health products in their portfolio. Organon India will be operating with their in-house sales force and alliance partners across the various markets.said Anjan Sen, who will lead the operations for India and countries in south Asia region.

Source: Economic Times June 03, 2021 05:50 UTC